Turnstone Biologics Faces Delisting Concerns
| Field | Detail |
|---|---|
| Company | Turnstone Biologics Corp. |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: TSBX
TL;DR
TSBX might get delisted, check listing rules.
AI Summary
Turnstone Biologics Corp. filed an 8-K on April 1, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the effective date of change being March 31, 2025. The company, incorporated in Delaware, is in the biological products sector and is headquartered in La Jolla, California.
Why It Matters
This filing indicates potential issues with Turnstone Biologics' continued listing on an exchange, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status and investor confidence.
Key Numbers
- 001-41747 — Commission File Number (Identifies the company's SEC filing history.)
- 83-2909368 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Turnstone Biologics Corp. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- March 31, 2025 (date) — Date as of change
- April 1, 2025 (date) — Filing Date
- La Jolla, California (location) — Principal Executive Offices
FAQ
What specific listing rule or standard has Turnstone Biologics failed to satisfy?
The filing does not specify the exact rule or standard that Turnstone Biologics has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the effective date of the delisting or failure to satisfy the listing rule?
The date as of change is March 31, 2025.
When was this 8-K form filed with the SEC?
The 8-K form was filed as of April 1, 2025.
What is Turnstone Biologics Corp.'s primary business?
Turnstone Biologics Corp. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
Where are Turnstone Biologics Corp.'s principal executive offices located?
The principal executive offices are located at 9310 Athena Circle, Suite 300, La Jolla, California, 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Turnstone Biologics Corp..